MackTRuffinIVMDMPH

PubMed

• 30 citations
  Phase II Study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer
  Suzanna M. Zick, D. Kim Turgeon, Shaiju K. Vareed, Mack T. Ruffin, Amie J. Litzinger
  Cancer Prevention Research. 2011-11-01
• 13 citations
  Challenges in herbal research: a randomized clinical trial to assess blinding with ginger.
  Suzanna M. Zick, Amy Blume, Daniel P. Normolle, Mack T. Ruffin
  Complementary Therapies in Medicine. 2005-06-01
• 29 citations
  Effect of ginger root on cyclooxygenase-1 and 15-hydroxyprostaglandin dehydrogenase expression in colonic mucosa of humans at normal and increased risk for colorectal ...
  Yan Jiang, D.K. Turgeon, Benjamin D. Wright, Elkhansa Sidahmed, Mack T. Ruffin
  European Journal of Cancer Prevention. 2013-09-01

Journal Articles

• The human gut microbiome as a screening tool for colorectal cancer  
  Zackular JP, Rogers MA, Ruffin MT 4th, Schloss PD, Cancer Prev Res (Phila), 8/7/2014
• Screening and prevention in primary care  
  Ruffin MT 4th, Shultz CG, Prim Care, 6/1/2014
• Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer  
  Zick SM, Turgeon DK, Ren J, Ruffin MT, Wright BD, Sen A, Djuric Z, Brenner DE, Mol Carcinog, 4/24/2014
• Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis  
  Nie S, Lo A, Wu J, Zhu J, Tan Z, Simeone DM, Anderson MA, Shedden KA, Ruffin MT, Lubman DM, J Proteome Res, 1/1/2014
• Development and initial feedback about a human papillomavirus (hpv) vaccine comic book for adolescents  
  Katz ML, Oldach BR, Goodwin J, Reiter PL, Ruffin MT 4th, Paskett ED, Cancer Educ, 1/1/2014
• Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-MS/MS  
  Lin Z, Yin H, Lo A, Ruffin MT, Anderson MA, Simeone DM, Lubman DM, Electrophoresis, 11/27/2013
• Serum metabolomic analysis of pancreatic cancer--Letter  
  Shakour S, Ruffin MT, Zick SM, Lubman DM, Nie S, Cancer Epidemiol Biomarkers Prev, 10/1/2013
• Effects of ginger supplementation on cell cycle biomarkers in the normal-appearing colonic mucosa: results from a pilot, randomized, controlled trial  
  Citronberg J, Bostick RM, Ahearn TU, Turgeon DK, Ruffin MT, Djuric Z, Sen A, Brenner DE, Zick SM, Cancer Prev Res (Phila), 1/1/2013
• Isobaric protein-level labeling strategy for serum glycoprotein quantification analysis by liquid chromatography-tandem mass spectrometry  
  Nie S, Lo A, Zhu J, Wu J, Ruffin MT, Lubman DM, Anal Chem, 1/1/2013
• Depression and SES in women from Appalachia  
  Post DM, Gehlert S, Hade EM, Reiter PL, Ruffin M, Paskett ED, Journal of Rural Mental Health, 1/1/2013
• Decision Aid to Technologically Enhance Shared decision making (DATES): study protocol for a randomized controlled trial  
  Jimbo M, Kelly-Blake K, Sen A, Hawley ST, Ruffin IV MT, Trials, 1/1/2013
• Perceived barriers and facilitators of using a web-based interactive decision aid for colorectal cancer screening in community practice settings: findings from focus g...  
  Jimbo M, Shultz CG, Nease DE, Fetters MD, Power D, Ruffin MT 4th, J Med Internet Res, 1/1/2013
• HPV testing for normal cervical cytology in low-risk women age 30-65 years by family physicians  
  de la Cruz MD, Young AP, Ruffin MT IV, J Am Board Fam Med, 1/1/2013
• Family history assessment: impact on disease risk perceptions  
  Wang C, Sen A, Ruffin MT, IV, Nease DE, Jr., Gramling R, Acheson LS, O’Neill SM, Rubinstein WS; for the Family HealthwareTM Impact Trial (FHITr) Group, Am J Prev Med, 1/1/2012
• Patterns of cellular and HPV 16 methylation as biomarkers for cervical neoplasia  
  Patel DA, Rozek LS, Colacino JA, Van Zomeren-Dohm A, Ruffin MT, Unger ER, Dolinoy DC, Swan DC, Onyekwuluje J, Degraffinreid CR, Paskett ED, J Virol Methods, 1/1/2012
• A Mediterranean dietary intervention in persons at high risk of colon cancer: Recruitment and retention to an intensive study requiring biopsies  
  Djuric Z, Ruffin MT 4th, Rapai ME, Cornellier ML, Ren J, Ferreri TG, Askew L, Sen A, Brenner DE, Turgeon DK, Contemp Clin Trials, 1/1/2012
• Microsatellite instability and DNA mismatch repair protein deficiency in lynch syndrome colorectal polyps  
  Yurgelun MB, Goel A, Hornick JL, Sen A, Turgeon DK, Ruffin MT 4th, Marcon NE, Baron JA, Bresalier RS, Syngal S, Brenner DE, Boland CR, Stoffel EM, Cancer Prev Res (Phila), 1/1/2012
• Clinical utility of family history for cancer screening and referral in primary care: A report from the Family Healthware Impact Trial  
  Genet Med, 1/1/2011
• Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test  
  Ruffin MT, Normolle DP, Evelegh MJ, Baron JA, Bresalier RS, Marcon NE, Syngal S, Turgeon DK, Tuck MK, Brenner DE, Cancer Biomark, 1/1/2011
• Effect of preventive messages tailored to family history on health behaviors: The Family Healthware Impact Trial  
  Ruffin MT 4th, Nease DE Jr, Sen A, Pace WD, Wang C, Acheson LS, Rubinstein WS, O'Neill S, Gramling R; for The Family History Impact Trial (FHITr) Group, Ann Fam Med, 1/1/2011
• Maternal characteristics that predict a preference for mandatory adolescent HPV vaccination  
  Carlos RC, Dempsey AF, Resnicow K, Ruffin M, Patel DA, Straus CM, Vanessa K D, Hum Vaccine, 1/1/2011
• Feasibility of using maternal cancer screening visits to identify adolescent girls eligible for HPV vaccination  
  Carlos RC, Dempsey AF, Ruffin MT 4th, Patel DA, Straus CM, Kure A, Dalton VK, J Womens Health (Larchmt), 1/1/2010
• Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system  
  Dempsey A, Cohn L, Dalton V, Ruffin M, Vaccine, 1/1/2010
• Familial risk for common diseases in primary care: The Family HealthwareTM Impact Trial  
  O’Neill SM, Rubinstein WS, Wang C, Yoon PW, Acheson LS, Rothrock N, Starzyk EJ, Beaumont JL, Galliher JM, Ruffin MT IV, for the Family HeathwareTM Impact Trial Group, Am J Prev Med, 1/1/2009
• Measuring cervical cancer risk: development and validation of the CARE Risky Sexual Behavior Index  
  Reiter PL, Katz ML, Ferketich AK, Ruffin MT, Paskett ED, Cancer Causes Control, 1/1/2009
• Join now to see all

Abstracts/Posters

• Decisions to share results and seek further information following online personal genetic testing
  Wang C, Dalia A, Roberts JS, Kalia S, Chen C, Ruffin M, Lehmann L, Mountain J, Moreno T, Green RC, Ann Behav Med, 1/1/2014
• Screening for Lung Cancer
  Ruffin MT, Department of Family Medicine Updates in Family Medicine Conference (CME course), Ann Arbor, MI, 10/3/2013
• Integrating Lung Cancer Screening Into Your Practice
  Ruffin MT, Department of Family Medicine Updates in Family Medicine Conference (CME course), Ann Arbor, MI, 10/3/2013
• A CD83 SNP is associated with abnormal Pap test results in high-risk Ohio Appalachian women
  Perrault JT, Ogbemudia BE, Sears ML, DeGraffinreid CR, Zhu DQ, Lu B, Cohn DE, Knobloch TJ, Ruffin MT, Paskett ED, Weghorst CM, Cancer Res, 1/1/2013
• Genetic Screening for Common Disease: Ready for Primary Care?
  Ruffin MT, Department of Family Medicine Northern Michigan Summer Conference (CME course), Bellaire, MI, 6/19/2012
• HPV Vaccine and Screening
  Ruffin MT, Department of Family Medicine Northern Michigan Summer Conference (CME course), Bellaire, MI, 6/19/2012
• Adult Vaccine Update
  Ruffin MT, Department of Family Medicine Northern Michigan Summer Conference (CME course), Bellaire, MI, 6/18/2012
• Screening Strategies for Lung Cancer
  Ruffin MT, Department of Family Medicine Northern Michigan Summer Conference (CME course), Bellaire, MI, 6/18/2012
• Updates on Cancer Screening
  Ruffin MT, Department of Family Medicine Northern Michigan Summer Conference (CME course), Bellaire, MI, 6/18/2012
• Fatty Acid Supplementation
  Ruffin MT, Department of Family Medicine MidWinter Family Medicine Update (CME course), Boyne, MI, 2/2/2012
• Health Issues of Children at Summer Camp, it is Not Wilderness Medicine
  Ruffin MT, Department of Family Medicine MidWinter Family Medicine Update (CME course), Boyne, MI, 2/1/2012
• Screening for Lung Cancer
  Ruffin MT, Department of Family Medicine MidWinter Family Medicine Update (CME course), Boyne, MI, 1/31/2012
• Regulation of ginger root extract on colonic inflammatory signaling in human with normal and high risk of colon cancer
  Jiang Y, Turgeon DK, Wright BD, Ruffin MT, Brenner DE, Zick SM, Pharm Biol, 1/1/2012
• Sensitivity and specificity of fecal immunochemical and guaiac testing for occult blood in archived frozen stool samples
  Nguyen D, Tuck M, Sen A, Ruffin MT, Baron JA, Bresalier RS, Marcon NE, McConnell D, Stoffel EM, Syngal S, Brenner DE, Turgeo, DK, Gastroenterology, 1/1/2012
• Cervical cancer prevention among women living in rural populations: the example of Ohio Appalachia
  Paskett ED, Ferketich A, Ruffin MT, Thompson B, Ann Behav Med, 1/1/2010
• The impact of family history assessment on disease risk perceptions: results from The Family Healthware Impact Trial (FHITR)
  Wang C, Gramling R, Sen A, Ruffin MT, Nease DE, Acheson LS, O'Neill SM, Rubinstein WS, Ann Behav Med, 1/1/2010
• HPV vaccine utilization by young adult women: are the highest risk populations being vaccinated?
  Dempsey AF, Cohn L, Dalton V, Ruffin MT, J Women Health, 1/1/2010
• Update on HPV Vaccinations
  Ruffin MT, 18th Annual Primary Health Care of Women (CME course), Boyne, MI, 12/1/2009
• Update on adolescent vaccine
  Ruffin MT, Department of Family Medicine CME courses, Boyne, MI, 2/1/2009
• Shingles update: Vaccine, diagnosis, & treatment
  Ruffin MT, Department of Family Medicine CME courses, Boyne, MI, 2/1/2009
• HPV – The Basics and Beyond
  Ruffin MT, Gynecology, Cancer & Women, University of Michigan, School of Nursing conference, Ann Arbor, MI, 11/1/2008
• HPV papillomavirus vaccine knowledge and acceptance among women in Appalachia (poster presentation)
  Ruffin MT IV, Hade EM, Gorsline MR, DeGraffinreid CR, Katz ML, Kobrin SC, Paskett ED, 27th International Papillomavirus Conference, Berlin, Germany, 9/11/2008
• The relationship between self-identity and depression in women from Appalachia, Ohio
  Post DM, Ruffin R, Reiter P, Hade EM, deMoor J, Paskett ED, NCI Cancer Health Disparities Summit 2008, Bethesda, MD, 7/1/2008
• Reasons why parents do or do not get their daughters vaccinated against HPV
  Dempsey AF, Abraham L, Dalton V, Ruffin M, Pediatric Academic Societies National Meeting, Honolulu, HI, 5/1/2008
• Human Papillomavirus (HPV) vaccine acceptance among residents of Ohio Appalachia (poster presentation)
  Katz ML, Heaner S, Reiter P, Ruffin M, Post D, Paskett ED, American Society of Preventive Oncology, Bethesda, MD, 3/1/2008
• Join now to see all

Lectures

• HPV and cancer 
  Columbus, OH - 4/3/2014
• Ginger supplementation and the expression of NF-kB in the normal-appearing colorectal mucosa of patients at high risk of colorectal cancer: results from a pilot random... 
  Hilo, HI - 12/12/2011
• Appalachian self-identity and its effects on cervical cancer screening and risky sexual behavior among women in Ohio Appalachia 
  San Diego, CA - 10/28/2008
• Human Papillomavirus (HPV) vaccine knowledge and attitudes among women in Appalachia Ohio 
  San Diego, CA - 10/28/2008
• Socioeconomic barriers to Pap smear utilization among Ohio Appalachian women 
  San Diego, CA - 10/28/2008
• Human Papillomavirus (HPV) vaccine acceptance in Ohio Appalachia 
  San Diego, CA - 10/28/2008
• Use of HPV testing in low risk women ages 30-65 
  Berlin, Germany - 9/11/2008
• The relationship between self-identity and depression in women from Appalachia, Ohio 
  Bethesda, MD - 7/1/2008
• The relationship between self-identity and depression in women from Appalachia Ohio 
  Bethesda, MD - 7/1/2008
• Colon rectal cancer screening 
  Huntington, WV - 11/10/2006
• Office systems and organization 
  Baltimore, MD - 3/16/2006
• Barriers to colorectal screening 
  Lansing, MI - 9/9/2004
• Colorectal Cancer Prevention: Screening 
  Memorial Hospital, South Bend, IN - 6/23/2004
• Changing cancer screening practices of community primary care practices 
  Cleveland, OH - 5/21/2004
• Cervical cancer: Chemoprevention and biomarker development 
  Cleveland, OH - 5/21/2004
• Family history tool for PCPs or Family Assessment of Risk Evaluation (FARE) Trial 
  One Ford Place, Detroit, MI - 5/7/2004
• Development of an interactive educational electronic program to promote colorectal cancer screening 
  Philadelphia, PA - 3/1/2003
• Topical all-trans retinoic acid for CIN II/III 
  Philadelphia, PA - 3/1/2003
• RCT of a new interactive electronic program to promote colorectal cancer screening 
  Philadelphia, PA - 3/1/2003
• Diet, HPV and cervical dysplasia 
  Atlanta, GA - 11/1/2001
• Put prevention into practice 
  Lakeland Hospital, St. Joseph, MI - 9/1/1998
• To screen or not to screen: The persistent dilemma 
  Dearborn, MI - 11/1/1997
• Screening for colorectal cancer 
  Toledo, OH - 10/1/1997
• Controversies in preventive services: Breast cancer screening and prostate cancer screening 
  Grand Rapids, MI - 9/1/1997
• Aspirin as a chemopreventive agent for colorectal cancer: Lowest dose of aspirin to suppress rectal mucosal prostaglandins 
  Toronto, Ontario, Canada - 3/1/1995
• Join now to see all